BackRhythm Pharmaceuticals Overview

Rhythm Pharmaceuticals Net Income

Profitability analysis for RYTM.

Quarterly Net Income

-$55.64M
12.41% YoY

As of Mar 2026

Annual Net Income (TTM)

-$208.06M
22.37% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...